Literature DB >> 9526808

Atherogenicity of triglyceride-rich lipoproteins.

R M Krauss1.   

Abstract

There is increasing evidence that alterations in metabolism of triglyceride-rich lipoproteins are of importance in the pathogenesis of atherosclerosis and its clinical consequences. Particles with the characteristics of triglyceride-rich lipoprotein remnants have been related to the extent and severity of atherosclerosis in humans and in animal models. These particles can be identified using ultracentrifugal procedures as small, very low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL) with Svedberg flotation rates (Sf) of 12-60. Postprandial triglyceride levels also have been related to risk of coronary artery disease, consistent with a pathologic role for remnant lipoproteins. In studies in which measurements of lipoprotein subfractions have been carried out, levels of IDL have been more predictive than low-density lipoprotein (LDL) of atherosclerosis progression as assessed by coronary artery angiography or carotid artery ultrasonography. These findings suggest that a considerable portion of the coronary disease risk attributed to LDL may be accounted for by the IDL particles included in standard LDL measurements. Other metabolic changes associated with increased levels of plasma triglyceride may also adversely affect cardiovascular disease risk. These include reductions in HDL-cholesterol and apoprotein A1, increased levels of small dense LDL particles, redistribution of apoC-III from HDL to apoB-containing lipoproteins, diminished insulin sensitivity, and procoagulant changes, including increased levels of the fibrinolysis inhibitor, plasminogen-activator inhibitor-1 (PAI-1). A predominance of small dense LDL (subclass pattern B) is a discrete marker for this cluster of interrelated abnormalities and is found in 40-50% of patients with coronary artery disease. Therapeutic interventions with favorable effects on components of this dysmetabolic profile appear to be of value in decreasing atherosclerosis risk in a substantial proportion of the population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526808     DOI: 10.1016/s0002-9149(98)00032-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

Review 1.  Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Authors:  H Robert Superko; Radhika R Gadesam
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

2.  Correlation between biochemical indicators of blood lipid with cerebral vascular diseases.

Authors:  Dongmei Wang; Jun Hu; Qiao Ma; Jiarui Ma; Binjian Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Marked Differences of Haplotype Tagging SNP Distribution, Linkage, and Haplotype Profile of APOA5 Gene in Roma Population Samples.

Authors:  Katalin Sumegi; Balazs Duga; Bela I Melegh; Zsolt Banfai; Erzsebet Kovesdi; Anita Maasz; Bela Melegh
Journal:  Pathol Oncol Res       Date:  2017-01-19       Impact factor: 3.201

4.  Effects of oxidation on structural stability and remodeling of human very low density lipoprotein.

Authors:  Madhumita Guha; Olga Gursky
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

Review 5.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

6.  ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice.

Authors:  Guozhi Xiao; Ting Zhang; Shibing Yu; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Steven Ringquist; H Henry Dong
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

7.  FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

Authors:  Dae Hyun Kim; Ting Zhang; Sojin Lee; Virtu Calabuig-Navarro; Jun Yamauchi; Ann Piccirillo; Yong Fan; Radha Uppala; Eric Goetzman; H Henry Dong
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

Review 8.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Thermal transitions in human very-low-density lipoprotein: fusion, rupture, and dissociation of HDL-like particles.

Authors:  Madhumita Guha; Cheryl England; Haya Herscovitz; Olga Gursky
Journal:  Biochemistry       Date:  2007-05-01       Impact factor: 3.162

10.  Simple chemical syntheses of TAG monohydroperoxides.

Authors:  Shu-Ping Hui; Tsuyoshi Murai; Teruki Yoshimura; Hitoshi Chiba; Takao Kurosawa
Journal:  Lipids       Date:  2003-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.